6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
16m ago	Cebu Pacific Inaugurates Modern Training Facility for Pilots, Cabin Crew
17m ago	Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
17m ago	Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
1h ago	NIQ Insights: Asia Pacific Consumers Redefine Value Amid Ongoing Uncertainty
1h ago	Greenland Energy Announces Pricing of $70 Million Public Offering

About

Entrada Therapeutics Inc (NASDAQ:TRDA) — investor relations, events, news, and company updates on 6ix.

Latest News

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Entrada Therapeutics to Present at Upcoming Investor Conferences

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Financials

Revenue

$25.42 M

Market Cap

$503.44 M

EPS

-3.47

Community Chat

Ask AI